Nutra Pharma Announces Additional Orphan Drug Application for RPI-78M for the Treatment of Myastheni
December 09, 2015 December 9, 2015 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing...
StockNewsNow.com Publishes New SNNLive Video Interview With Nutra Pharma Corporation
October 27, 2015 LOS ANGELES, CA--(Marketwired - October 27, 2015) - StockNewsNow.com, The Official MicroCap News Source™, today...
Nutra Pharma's Rik Deitsch Interviewed by The Life Sciences Report
October 22, 2015 SAN FRANCISCO, CA--(Marketwired - October 22, 2015) - Nutra Pharma Corp. (OTC PINK: NPHC) is pursuing a strategy of...
Nutra Pharma To Present at Upcoming Investment Conference
September 09, 2015 Nutra Pharma is announcing that they will present at the upcoming See Thru Equities Conference in New York City on...
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration for the
September 08, 2015 September 8, 2015 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), announced today that they have...